183 related articles for article (PubMed ID: 32881663)
1. Interpretable SMILES-based QSAR Model of Inhibitory Activity of Sirtuins 1 and 2.
Worachartcheewan A; Toropova AP; Toropov AA; Pratiwi R; Prachayasittikul V; Nantasenamat C
Comb Chem High Throughput Screen; 2021; 24(8):1217-1228. PubMed ID: 32881663
[TBL] [Abstract][Full Text] [Related]
2. Use of the Monte Carlo Method for OECD Principles-Guided QSAR Modeling of SIRT1 Inhibitors.
Kumar A; Chauhan S
Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 28025857
[TBL] [Abstract][Full Text] [Related]
3. QSAR Differential Model for Prediction of SIRT1 Modulation using Monte Carlo Method.
Kumar A; Chauhan S
Drug Res (Stuttg); 2017 Mar; 67(3):156-162. PubMed ID: 27992935
[TBL] [Abstract][Full Text] [Related]
4. Design and development of novel focal adhesion kinase (FAK) inhibitors using Monte Carlo method with index of ideality of correlation to validate QSAR.
Kumar P; Kumar A; Sindhu J
SAR QSAR Environ Res; 2019 Feb; 30(2):63-80. PubMed ID: 30793981
[TBL] [Abstract][Full Text] [Related]
5. CORAL: Monte Carlo based global QSAR modelling of Bruton tyrosine kinase inhibitors using hybrid descriptors.
Ahmadi S; Lotfi S; Afshari S; Kumar P; Ghasemi E
SAR QSAR Environ Res; 2021 Dec; 32(12):1013-1031. PubMed ID: 34875951
[TBL] [Abstract][Full Text] [Related]
6. Combinations of graph invariants and attributes of simplified molecular input-line entry system (SMILES) to build up models for sweetness.
Achary PGR; Toropova AP; Toropov AA
Food Res Int; 2019 Aug; 122():40-46. PubMed ID: 31229093
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
[TBL] [Abstract][Full Text] [Related]
8. The Monte Carlo technique as a tool to predict LOAEL.
Veselinović JB; Veselinović AM; Toropova AP; Toropov AA
Eur J Med Chem; 2016 Jun; 116():71-75. PubMed ID: 27060758
[TBL] [Abstract][Full Text] [Related]
9. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.
Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G
Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641
[TBL] [Abstract][Full Text] [Related]
10. Sirtuins 1 and 2 Are Universal Histone Deacetylases.
Hsu WW; Wu B; Liu WR
ACS Chem Biol; 2016 Mar; 11(3):792-9. PubMed ID: 26820517
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Biological Evaluation of 8-Mercapto-3,7-Dihydro-1
Han H; Li C; Li M; Yang L; Zhao S; Wang Z; Liu H; Liu D
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549218
[TBL] [Abstract][Full Text] [Related]
13. CORAL Software: Analysis of Impacts of Pharmaceutical Agents Upon Metabolism via the Optimal Descriptors.
Toropova MA; Raska I; Toporova AP; Raskova M
Curr Drug Metab; 2017; 18(6):500-510. PubMed ID: 28260514
[TBL] [Abstract][Full Text] [Related]
14. CORAL: Monte Carlo Method to Predict Endpoints for Medical Chemistry.
Toropova AP; Toropov AA
Mini Rev Med Chem; 2018 Feb; 18(5):382-391. PubMed ID: 28971771
[TBL] [Abstract][Full Text] [Related]
15. coral Software: QSAR for Anticancer Agents.
Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
[TBL] [Abstract][Full Text] [Related]
16. QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells.
Toropov AA; Toropova AP; Puzyn T; Benfenati E; Gini G; Leszczynska D; Leszczynski J
Chemosphere; 2013 Jun; 92(1):31-7. PubMed ID: 23566368
[TBL] [Abstract][Full Text] [Related]
17. Consensus QSAR modelling of SIRT1 activators using simplex representation of molecular structure.
Chauhan S; Kumar A
SAR QSAR Environ Res; 2018 Apr; 29(4):277-294. PubMed ID: 29390919
[TBL] [Abstract][Full Text] [Related]
18. Use of Simplified Molecular Input Line Entry System and molecular graph based descriptors in prediction and design of pancreatic lipase inhibitors.
Kumar A; Chauhan S
Future Med Chem; 2018 Jul; 10(13):1603-1622. PubMed ID: 30028205
[TBL] [Abstract][Full Text] [Related]
19. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
[TBL] [Abstract][Full Text] [Related]
20. In silico design of diacylglycerol acyltransferase-1 (DGAT1) inhibitors based on SMILES descriptors using Monte-Carlo method.
Kumar P; Kumar A; Sindhu J
SAR QSAR Environ Res; 2019 Aug; 30(8):525-541. PubMed ID: 31331203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
